CMS Sees Role For Drug Manufacturers In Electronic Prescribing Incentives
This article was originally published in The Pink Sheet Daily
The Centers for Medicare & Medicaid Services should look at ways for drug manufacturers to legally supply e-prescribing equipment and training to providers, Deputy Administrator Norwalk says. A proposed rule on safe harbors for hospitals and insurance plans will be released soon.
You may also be interested in...
A possible settlement between Merck and tax authorities could be significantly smaller than GlaxoSmithKline's recent settlement with the IRS based on the companies' projected liability
Pfizer's success will depend on its ability to negotiate the paradox of increasing demand for pharmaceuticals coupled with growing attempts to restrain costs, CEO Jeffrey Kindler said
Pfizer will continue to support the insomnia product for up to six months.